86 related articles for article (PubMed ID: 15364174)
1. Can the genotoxicity of chemotherapy be predicted?
Pui CH; Relling MV
Lancet; 2004 Sep 11-17; 364(9438):917-8. PubMed ID: 15364174
[No Abstract] [Full Text] [Related]
2. Surprise at genotoxicity findings for childhood leukaemia therapy.
Whelan J
Drug Discov Today; 2004 Sep; 9(17):731-2. PubMed ID: 15450234
[No Abstract] [Full Text] [Related]
3. Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II.
Pedersen-Bjergaard J
Leuk Res; 1992 Aug; 16(8):733-5. PubMed ID: 1326684
[No Abstract] [Full Text] [Related]
4. On the malignant potential of thiopurine therapy.
de Boer NK; van Asseldonk DP; van Bodegraven AA
Blood; 2009 Jun; 113(24):6258; author reply 6258-9. PubMed ID: 19520817
[No Abstract] [Full Text] [Related]
5. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.
Rice SC; Vacek P; Homans AH; Messier T; Rivers J; Kendall H; Finette BA
Cancer Res; 2004 Jul; 64(13):4464-71. PubMed ID: 15231655
[TBL] [Abstract][Full Text] [Related]
6. Emergence of genetic instability in children treated for leukemia.
Finette BA; Homans AC; Albertini RJ
Science; 2000 Apr; 288(5465):514-7. PubMed ID: 10775110
[TBL] [Abstract][Full Text] [Related]
7. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
8. Measurement of mutation frequency at the HPRT locus in peripheral lymphocytes. Is this a good method to evaluate a cancer risk in pediatric patients?
Lin YW; Kubota M; Akiyama Y; Sawada M; Furusho K
Adv Exp Med Biol; 1998; 431():681-6. PubMed ID: 9598152
[TBL] [Abstract][Full Text] [Related]
9. Ethics. Did the NHS fail child B?
Nurs Times; 1996 Sep 4-10; 92(36):33-6. PubMed ID: 8868766
[No Abstract] [Full Text] [Related]
10. Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia.
Hirota H; Kubota M; Hashimoto H; Adachi S; Matsubara K; Kuwakado K; Akiyama Y; Tsutsui T; Mikawa H
Mutat Res; 1993 Oct; 319(2):113-20. PubMed ID: 7692286
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
Kendall HE; Vacek PM; Finette BA
Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
[TBL] [Abstract][Full Text] [Related]
12. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
Sandoval C; Jayabose S
Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
Klin Padiatr; 2008; 220(6):388-90. PubMed ID: 18949677
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II.
Pedersen-Bjergaard J
Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010
[No Abstract] [Full Text] [Related]
15. Boerhaave syndrome following chemotherapy in a child with acute lymphoblastic leukemia.
Dagash HI; Baillie C; Lawson RA; Will AM
Pediatr Blood Cancer; 2004 Jul; 43(1):91-2. PubMed ID: 15170899
[No Abstract] [Full Text] [Related]
16. Second primary tumours (SPTs) after chemotherapy.
Cartei G; Liguori S; Tabaro G; Cartei F
Eur J Cancer Prev; 1996 Oct; 5(5):400-2. PubMed ID: 8972275
[No Abstract] [Full Text] [Related]
17. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
Larson RA
J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
[No Abstract] [Full Text] [Related]
18. The epipodophyllotoxins: both sides of the coin.
Rivera GK; Pui CH; Crist WM
J Clin Oncol; 1993 Aug; 11(8):1624-5. PubMed ID: 8336199
[No Abstract] [Full Text] [Related]
19. Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Ozga M; Blachly J; Eisfeld AK; Grieselhuber N; Larkin K; Walker A; Bhatnagar B; Behbehani G; Long M; Haque T; Vasu S; Zhao W; Jones D; Byrd JC; Mims AS; Saygin C
Am J Hematol; 2021 Jul; 96(7):E223-E225. PubMed ID: 33761147
[No Abstract] [Full Text] [Related]
20. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
